Also trades as: 4582.T (JPX) · $vol 0M
SYMQY OTC
SymBio Pharmaceuticals Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -12.4%
1Y: -41.5%
3Y: -92.0%
5Y: -77.2%
$0.56
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$26.4M
52W Range0.5579-0.899
Volume1
Avg Volume245
Beta0.53
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOFuminori Yoshida
Employees91
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2016-08-05
Websitesymbiopharma.com
Toranomon Towers Office
Tokyo, TY 105-0001
JP
Tokyo, TY 105-0001
JP
81 3 5472 1125
About SymBio Pharmaceuticals Limited
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded by Fuminori Yoshida on March 25, 2005 and is headquartered in Tokyo, Japan.
Latest News
No recent news
Recent Insider Trades
No insider trades found